---
title: "New Weight Loss Drug Outperformed Existing Treatment in Clinical Trial"
date: 2025-08-27T19:40:07.328Z
source: "sciencealert.com"
source_url: https://www.sciencealert.com/new-weight-loss-drug-outperformed-existing-treatment-in-clinical-trial
---

## Shrnutí (CZ)
Under brand names like Ozempic and Wegovy, semaglutide-based medications have made a significant difference in treating type 2  diabetes and obesity. After a successful phase 3 trial, a new kind of treatment based on the same mechanics could deliver even more impressive weight-loss results. Like semaglutide, the new drug known as ecnoglutide is glucagon-like peptide-1 receptor agonist.

---

[Otevřít zdroj](https://www.sciencealert.com/new-weight-loss-drug-outperformed-existing-treatment-in-clinical-trial)
